Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 1.00 |
| ▸ | PDE5A | O76074 | 1/20 | 1.00 |
| ▸ | CA1 | P00915 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 1/20 | 1.00 |
| ▸ | HMGCR | P04035 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | LCK | P06239 | 1/20 | 1.00 |
| ▸ | FYN | P06241 | 1/20 | 1.00 |
| ▸ | HSPD1 | P10809 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CA6 | P23280 | 1/20 | 1.00 |
| ▸ | TBXAS1 | P24557 | 1/20 | 1.00 |
| ▸ | MAPK3 | P27361 | 1/20 | 1.00 |
| ▸ | HSPE1 | P61604 | 1/20 | 1.00 |
| ▸ | MAPK14 | Q16539 | 1/20 | 1.00 |
| ▸ | TST | Q16762 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tannic Acid SCHEMBL17432880 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| Tannic Acid SCHEMBL17079060 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| SCHEMBL13170284 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| Tannic Acid SCHEMBL22105299 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| SCHEMBL23630701 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| Tannic Acid SCHEMBL743760 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| SCHEMBL23630733 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| SCHEMBL23630709 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| Tannic Acid SCHEMBL25066810 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 | |
| Tannic Acid SCHEMBL21865640 | 1.00 | USP2 (1.00) | USP2MAPK1TMPRSS2PDE5ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026086-A1 | POLYPHENOL DERIVATIVE AND POLYMER MATERIAL | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240026086-A1 | POLYPHENOL DERIVATIVE AND POLYMER MATERIAL | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2024-01-25 | — | — | US | disclosed |
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-10 | — | — | US | disclosed |
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-10 | — | — | US | disclosed |
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-10 | — | — | US | disclosed |
| US-11382924-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-07-12 | — | — | US | disclosed |
| US-11382924-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-07-12 | — | — | US | disclosed |
| US-20220152069-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-05-19 | — | — | US | disclosed |
| US-20220152069-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-05-19 | — | — | US | disclosed |
| US-20220054516-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-02-24 | — | — | US | disclosed |
| US-20120123043-A1 | HOT MELT ADHESIVE COMPOSITION | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-05-17 | — | — | US | disclosed |
| US-20120064061-A1 | ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF | INNOTHERAPY INC. (KR) | 2012-03-15 | — | — | US | disclosed |
| US-20120064061-A1 | ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF | INNOTHERAPY INC. (KR) | 2012-03-15 | — | — | US | disclosed |
| US-20110038965-A1 | TOPICAL FORMULATION AND USES THEREOF | ARTHRITIS RELIEF PLUS LTD. (AU) | 2011-02-17 | — | — | US | disclosed |
| US-20110038965-A1 | TOPICAL FORMULATION AND USES THEREOF | ARTHRITIS RELIEF PLUS LTD. (AU) | 2011-02-17 | — | — | US | disclosed |
| WO-2010076112-A2 | FOOD PRODUCTS ENRICHED WITH METHYLXANTHINES | UNILEVER PLC (GB) | 2010-07-08 | — | — | WO | disclosed |
| WO-2010072671-A1 | FOOD COMPOSITION CONTAINING POLYPHENOLS | UNILEVER PLC (GB) | 2010-07-01 | — | — | WO | disclosed |
| US-20100151106-A1 | Food Composition Containing Polyphenols | CONOPCO, INC., D/B/A UNILEVER (US) | 2010-06-17 | — | — | US | disclosed |
| US-20100151106-A1 | Food Composition Containing Polyphenols | CONOPCO, INC., D/B/A UNILEVER (US) | 2010-06-17 | — | — | US | disclosed |
| US-20090087916-A1 | Assay method for identifying drug candidate | ANGESMG, INC. (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120064061-A1 | ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF | EPCAM, ICAM1, VCAM1 | USP2 1407/4885MAPK1 3867/4885TMPRSS2 2210/4885 |
| US-20110038965-A1 | TOPICAL FORMULATION AND USES THEREOF | SYMPK, MMP13, MMP7 | USP2 4465/4885MAPK1 4078/4885TMPRSS2 618/4885 |
| US-20220152069-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | ACE, ACE2, FURIN | USP2 2534/4885MAPK1 3172/4885TMPRSS2 7/4885 |
| US-20220054516-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | ACE, ACE2, FURIN | USP2 2534/4885MAPK1 3172/4885TMPRSS2 7/4885 |
| US-11382924-B2 | Compounds and pharmaceutical uses thereof | ACE, ACE2, FURIN | USP2 2534/4885MAPK1 3172/4885TMPRSS2 7/4885 |
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | ACE, ACE2, FURIN | USP2 2534/4885MAPK1 3172/4885TMPRSS2 7/4885 |
| US-20090087916-A1 | Assay method for identifying drug candidate | IAPP, APP, PCNP | USP2 1359/4885MAPK1 3641/4885TMPRSS2 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.